|
|
|
|
Businessuite 2021 Top 10 Jamaica Junior Market CEO by % change in US$ Profit after Tax |
|
|
|
|
NR |
NR |
NR |
|
|
|
US$000 |
US$000 |
% |
2021 |
2020 |
2019 |
|
Company |
Chief Executive Officer (CEO) |
2021/2020 |
2020/2019 |
2021 Change |
1 |
8 |
|
JA |
Indies Pharma Jamaica Limited |
Dr. Guna Muppuri |
$1,454 |
$988 |
47.14% |
Dr. Guna Muppuri
An entrepreneur at heart, Dr. Guna Muppuri is a Medical Doctor by profession and the Founder of the Company. He has over 20 years’ experience in the medical field inclusive of 15 years’ experience as the founder and Chief Executive Officer of the Company. He currently sits on the Audit and Compensation committees of the Board.
Dr. Muppuri, holds a MBBS degree from the S.V University Medical College in Tirupati, India. He migrated to Jamaica in early 1992 and has worked in various capacities (private and public) as a medical officer in the Jamaican health care system.
He is also served as the President of the Business Process Industry Association of Jamaica and is a member of the Dean’s Advisory Board for the School of Health Professions University of Alabama at Birmingham, USA, Member of the Board of Directors for The University of Common Wealth Caribbean (UCC) in Jamaica, is currently a Director of Bioprist Pharmaceuticals NA LLC, USA, Bioprist Holdings Inc., Bioprist Las Americas Limited, Bioprist Pharmaceuticals Limited (India), Bioprist (BPO ICT) Knowledge Parks, Bioprist Institute of Health and Medical Sciences – BIHMS and WINFRA Development Consortium Limited – Las Marinas Resort Condominiums & Winfra Homes.
In 2008, Dr. Muppuri received the ‘Good Physician of the Year’ inaugural award from the Medical Association of Jamaica, in 2015 he was nominated for the “Civic Leadership Award” by the American Chamber of Commerce, and in 2016 he was nominated the “Entrepreneur of the Year Award” by the Jamaica Chamber of Commerce. Dr. Muppuri also engages in other business ventures, including developing IT BPO Knowledge Parks and real estate.
Indies Pharma Jamaica Limited
Jointly founded by a medical doctor, Dr. Guna Muppuri, and his wife Mrs. Vishnu Muppuri, Indies Pharma Jamaica Limited was incorporated in Jamaica on 09 December 2003 as a Pharmaceutical Distribution Company.
The Company is headquartered in a commercial complex in Freeport, Montego Bay, Jamaica. Its retail unit, the Trident Pharmacy business is located nearby in Sam Sharpe Square, Montego Bay, Jamaica. Having sold its first pharmaceutical on 18 April 2005, the company distributes over 150 prescription and non-prescription or ‘over the counter’ generic pharmaceutical products for Bioprist Holdings Limited under the ‘Bioprist Pharmaceuticals’ brand in addition to the new line of products being sold under Orthopedic and Joint Rehabilitation segment.
The Company currently services customers across all 14 parishes of the island, including over 400 pharmacies, private and public hospitals and government agencies including the National Health Fund as well as medical practitioners, and directly to individual end users. The Company strives to provide unique, quality, and affordable pharmaceutical and complementary products, and to maintain efficient and effective product distribution across the island. It also aims to be a leading and trusted pharmaceutical distribution company with strong customer relationships, a commitment to brand and product development, and a large and reliable distribution network.
The Company continues to be managed by its founding members and the newly appointed Non- Executive Directors, with the support of a professional team of approximately 60 Plus employees.
2020 Year In Review
During this year, like everybody we had to embrace the harsh reality of the ongoing Novel Corona Virus pandemic that has caused an irreparable and a devastating effect on the world economy and the functional infrastructure of healthcare all over the world. Despite the ongoing challenges due to COVID, we successfully diversified our product offerings by launching a totally new line of products targeting the orthopedic and joint rehabilitation segment.
The relatively recession proof pharmaceutical business gave us the strength to register a steady growth with year-on-year increase in our revenues and therefore, the net profits.
The support received from our customers and the valiant employees of Indies Pharma was second to none during this pandemic.
Despite the challenges faced due to COVID-19 pandemic, during the 2019-20 financial year, INDIES recorded a 5% or $36.5 million increase in the gross revenues from $725.45 million in 2019 to $765.95 million in 2020. Indies Pharma’s strategic business management recorded a sizable surge in its net profits which increased to $206.65 million, representing a 57.7% per cent jump in 2020 when compared to 2019 and the comprehensive income was at $278.06 million registering a 104.35% increase over the prior year.
Our unwavering approach to the business was in tandem with our prior year forecast “Investing into R & D to yield long-term growth and profits”. The company made a very bold move and successfully raised a growth capital of $805Million from the market. 50% of the bond proceeds allowed the company to acquire 3 acres of prime real estate in Ironshore, Montego Bay on the Elegant corridor delivering an instant capital gain of more than $70 million.
The balance of the proceeds was allocated towards our long-term growth plans, development, and approval process of two abbreviated new drugs at the United States Food & Drug Administration. The goal is to commercialize the two drugs on the US market by 2023, targeting the current market cap of US$740Mil for the two drugs under development.
Substantiating my above statement, we are well poised for stable growth while capitalizing on the opportunities created by COVID in the field of healthcare.
On behalf of the Board of Directors of ‘Indies Pharma Jamaica Limited’, I am pleased to report on the performance of the company for the financial year that ended on 31 October 2020, two years, and ten weeks after we got listed on the Junior Stock Market of the Jamaica Stock Exchange.
Extracted from Founder & Chairman’s Message
Dr. Guna Muppuri
Chairman of the Board
More Information
https://www.jamstockex.com/wp-content/uploads/2021/03/INDIES-PHARMA-Annual-Report-2020.pdf